Literature DB >> 21849697

Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.

Jen Kok, Qinning Wang, Lee C Thomas, Gwendolyn L Gilbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21849697      PMCID： PMC3187338          DOI： 10.1128/JCM.00752-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  13 in total

1.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.

Authors:  Duncan R MacCannell; Thomas J Louie; Dan B Gregson; Michel Laverdiere; Annie-Claude Labbe; Felicia Laing; Scott Henwick
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  First Australian isolation of epidemic Clostridium difficile PCR ribotype 027.

Authors:  Thomas V Riley; Sarah Thean; Graham Hool; Clayton L Golledge
Journal:  Med J Aust       Date:  2009-06-15       Impact factor: 7.738

4.  Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

Authors:  Abraham Goorhuis; Dennis Bakker; Jeroen Corver; Sylvia B Debast; Celine Harmanus; Daan W Notermans; Aldert A Bergwerff; Frido W Dekker; Ed J Kuijper
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

5.  PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

Authors:  S L Stubbs; J S Brazier; G L O'Neill; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

6.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  R Jaeschke; G Guyatt; D L Sackett
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

Review 7.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

8.  Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies.

Authors:  Renate J van den Berg; Hadi Aa Ameen; Takahiro Furusawa; Eric Cj Claas; Eric R van der Vorm; Ed J Kuijper
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

9.  Comparison of strain typing results for Clostridium difficile isolates from North America.

Authors:  Fred C Tenover; Thomas Akerlund; Dale N Gerding; Richard V Goering; Therése Boström; Anna-Maria Jonsson; Edith Wong; Alan T Wortman; David H Persing
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

10.  Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.

Authors:  Haihui Huang; Andrej Weintraub; Hong Fang; Carl Erik Nord
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948
View more
  7 in total

1.  Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.

Authors:  Thomas P Wyche; René F Ramos Alvarenga; Jeff S Piotrowski; Megan N Duster; Simone R Warrack; Gabriel Cornilescu; Travis J De Wolfe; Yanpeng Hou; Doug R Braun; Gregory A Ellis; Scott W Simpkins; Justin Nelson; Chad L Myers; James Steele; Hirotada Mori; Nasia Safdar; John L Markley; Scott R Rajski; Tim S Bugni
Journal:  ACS Chem Biol       Date:  2017-07-26       Impact factor: 5.100

Review 2.  Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.

Authors:  Ying M Tang; Christian D Stone
Journal:  Clin J Gastroenterol       Date:  2017-02-16

3.  Comparison of Multilocus Sequence Typing and the Xpert C. difficile/Epi Assay for Identification of Clostridium difficile 027/NAP1/BI.

Authors:  Tracy McMillen; Mini Kamboj; N Esther Babady
Journal:  J Clin Microbiol       Date:  2015-12-23       Impact factor: 5.948

Review 4.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.

Authors:  Marie Pichenot; Rozenn Héquette-Ruz; Remi Le Guern; Bruno Grandbastien; Clément Charlet; Frédéric Wallet; Sophie Schiettecatte; Fanny Loeuillet; Benoit Guery; Tatiana Galperine
Journal:  Infection       Date:  2017-01-24       Impact factor: 3.553

6.  C. difficile ribotype 027 or 176?

Authors:  Marcela Krutova; Jana Matejkova; Otakar Nyc
Journal:  Folia Microbiol (Praha)       Date:  2014-06-27       Impact factor: 2.099

7.  Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain.

Authors:  Andrew M Skinner; Laurica Petrella; Farida Siddiqui; Susan P Sambol; Christopher A Gulvik; Dale N Gerding; Curtis J Donskey; Stuart Johnson
Journal:  Emerg Infect Dis       Date:  2020-02       Impact factor: 6.883
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.